Related Experiment Video
Updated: Jun 3, 2025

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Chronic Cigarette Smoke Exposure Masks Pathological Features of Helicobacter pylori Infection While Promoting Tumor
Maeve T Morris1, Benjamin C Duncan1, M Blanca Piazuelo2
1Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, West Virginia.
Cigarette smoke may hide Helicobacter pylori infection symptoms but accelerate gastric cancer by increasing DNA damage. Smokers with H. pylori need screening to lower cancer risk.
Area of Science:
- Gastroenterology
- Oncology
- Microbiology
Background:
- Gastric cancer is a leading cause of death worldwide.
- Helicobacter pylori infection and cigarette smoking are major risk factors.
- The interaction between H. pylori and cigarette smoke (CS) in gastric cancer development is not fully understood.
Purpose of the Study:
- To investigate the direct impact of cigarette smoke on H. pylori pathogenesis and gastric cancer initiation.
Main Methods:
- Male C57BL/6 mice were infected with H. pylori and exposed to CS or filtered air (FA) for 8 weeks.
- Gastric morphology, inflammation, DNA damage, and precancerous lesions were assessed.
Main Results:
- CS exposure did not alter gross gastric morphology or inflammation in mock-infected mice.
- CS significantly blunted H. pylori-induced gastric inflammation, atrophy, and metaplasia.
- Despite reduced inflammation, CS increased DNA damage and accelerated dysplasia in H. pylori-infected mice.
Conclusions:
- Cigarette smoking may mask H. pylori infection's pathological signs while promoting DNA damage and accelerating gastric carcinogenesis.
- Smokers infected with H. pylori may have a silenced disease presentation but an increased risk of developing gastric cancer.
- Screening H. pylori-infected smokers is crucial for gastric cancer prevention.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

